Supercharge Your Innovation With Domain-Expert AI Agents!

Water-soluble stable lobaplatin derivative

A derivative, the technology of lobaplatin, applied in the field of water-soluble and stable derivatives of lobaplatin, can solve the problems of poor chemical stability, weak coordination ability, inconvenient clinical use, etc., and achieve good water solubility and high anticancer effect , the effect of good clinical application prospects

Inactive Publication Date: 2014-05-07
KUNMING INST OF PRECIOUS METALS +1
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, L-lactic acid is an a-hydroxy acid, and the oxygen on the hydroxyl group has a weak coordination ability with platinum (), so it is easy to Dissociated from platinum (), therefore, the chemical stability of lobaplatin is poor, and its aqueous solution is only stable for 4 hours. It is required to be used within 4 hours after clinically formulated as an injection, and the stability time in normal saline is 1.5-4 hours [Instructions for Lobaplatin for Injection; China New Drug Impurities, 2012, 21(19), 2321- 2325], it is inconvenient to use clinically, and improper use will also affect the curative effect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Water-soluble stable lobaplatin derivative
  • Water-soluble stable lobaplatin derivative
  • Water-soluble stable lobaplatin derivative

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0019] (1) Diiodine intermediate ( 1 ) preparation of

[0020] The carrier amine of Xinluoplatin trans-1,2-bis(aminomethyl)cyclobutane was synthesized according to the method reported in the literature [8]. Then, take 5 g (12 mmol) K 2 PtCl 4 , Dissolve in 80 ml of water, take 12 g (6×12 mmol) KI, dissolve in 20 ml of water, mix the two solutions at 35-40°C in the dark, after 2 hours, add trans- 20 ml of 1,2-bis(aminomethyl)cyclobutane solution (including 1.37 g, 12 mmol), a brownish-yellow precipitate precipitated, continued to stir for 4 hours, collected by filtration, washed with water and ethanol respectively, and vacuumed at 45°C Dry to obtain 6.28 g cis-[trans-1,2-bis(aminomethyl)cyclobutane diiodoplatinum ( )]( 1 ), the yield was 93%.

[0021] (2) Preparation of silver 3-hydroxy-1,1-cyclobutanedicarboxylate (2)

[0022] The leaving group 3-hydroxy-1,1-cyclobutanedicarboxylic acid was prepared according to the method of literature [9]. Take 3 g (19 mmol) of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a water-soluble stable lobaplatin derivative, namely, shionlobaplatin. The chemical name of the shionlobaplatin is cis-[trans-1,2-bis(aminomethyl) cyclobutane 3-hydroxy-1,1-cyclobutane dicarboxylate platinum as shown in the specification. The preparation of the water-soluble stable derivative shionlobaplatin comprises the steps of by taking K2[PtCl4] as a starting raw material in water, adding KI to the K2[PtCl4] so that K2[PtCl4) is transformed into K2PtI4, reacting the K2PtI4 with trans-1,2-bis(aminomethyl) cyclobutane to prepare a corresponding diiodine intermediate, and then carrying out an equimolar quantitative reaction between the diiodine intermediate and 3-hydroxy-1,1-cyclobutane dicarboxylic acid to obtain the target compound. The compound shionlobaplatin has the characteristics of good water solubility, high stability and high anti-cancer effect, and can be prepared into a freeze-dried powder or an aqueous solution for clinical treatment of cancers.

Description

technical field [0001] The invention relates to a stable water-soluble lobaplatin derivative-cis-[trans-1,2-bis(aminomethyl)cyclobutane 3-hydroxyl-1,1-cyclobutane dicarboxylic acid platinum ( )] (English name: cis-[trans-1.2-bis (methylamine)cyclobutane3-hydroxy-1,1-cyclobutanedicarboxylatoplatinum ( )]) and as an anticancer drug, belonging to the field of chemical pharmacy. Background technique [0002] Platinum drugs are a very important class of anticancer drugs and are the first choice for the treatment of common malignant tumors [Edited by Han Rui, Sun Yan. Chemoprevention and Drug Therapy of Cancer in the New Century. People's Military Medical Publishing House , 2005, Beijing], widely used in clinical treatment of cancer, according to the latest statistics, currently 50% of clinical combined chemotherapy regimens are based on platinum drugs or participate in compatibility [Dhar S & Lippard S J. Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07F15/00A61K31/282A61P35/00A61P35/02
Inventor 刘伟平楼丽广谌喜珠谢成英姜婧叶青松全海天常桥稳
Owner KUNMING INST OF PRECIOUS METALS
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com